Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination Agents
Hao Wang(Ningxia Medical University), Terry Roemer(Merck Canada Inc. (Canada)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jianping Pan(Merck & Co., Inc., Rahway, NJ, USA (United States)), John P. Santa Maria(Harvard University), Timothy C. Meredith(Novartis (Switzerland)), Todd A. Black(Merck & Co., Inc., Rahway, NJ, USA (United States)), Suzanne Walker(Harvard University), Debra McGuinness(Merck & Co., Inc., Rahway, NJ, USA (United States)), Amy Flattery(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul A. Mann(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul Zuck(Merck & Co., Inc., Rahway, NJ, USA (United States)), Christopher M. Tan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sang Hyub Lee(Seoul National University Hospital), Jing Su(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jenny Liu(Massachusetts Institute of Technology), Charles Gill(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lianzhu Liang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Xinwei She(University of Washington), Judy Hailey(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jin Wu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Susan Kales(Jackson Laboratory)
Cited by 137
Related Papers
Genomic Islands in the Pathogenic Filamentous Fungus Aspergillus fumigatus
|PLoS Genetics|2008|531
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
|Journal of the American Chemical Society|2014|365